Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
SillaJen Inc banner
S

SillaJen Inc
KOSDAQ:215600

Watchlist Manager
SillaJen Inc
KOSDAQ:215600
Watchlist
Price: 3 790 KRW -2.94% Market Closed
Market Cap: ₩523.5B
Write Note Create Alert Ask AI

SillaJen Inc
Investor Relations

SillaJen, Inc. develops oncolytic immunotherapeutics virus. The company is headquartered in Seoul, Seoul. The company went IPO on 2016-12-06. The Company’s major product is Pexa-Vec, which is in a global Phase 3 clinical trial that is used for the treatment of liver cancer. Additionally, it also offers oncolytic virus immunotherapeutics, including SJ-102, SJ-103, SJ-815, JX-929, JX-930, JX-963, JX-970 and others.970 and others.

Show more
Loading
215600
KOSPI 200
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Jaekyung Kim
CEO & Chairman of the Board
No Bio Available
Suk Song Myung
Chief Financial Officer
No Bio Available
Mr. Eun-Ki Min
Chief Accounting Officer and Executive Director
No Bio Available
Chan Kwon Hyuk M.D., Ph.D.
Chief Medical Officer
No Bio Available
Mee Yang Kyung Ph.D.
Head of R&D Strategic Planning
No Bio Available
Mr. Jeongseok Lee
Executive Officer
No Bio Available

Contacts

Address
SEOUL
Seoul
11F, O2 Tower, 83, Uisadang-daero, Yeongdeungpo-gu
Contacts
+8223682600
www.sillajen.com
sparklesyt

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 315,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.